跳至主要内容
临床试验/CTRI/2021/10/037525
CTRI/2021/10/037525尚未招募未知

The Effect of Intrapartum Azithromycin on the Trajectory of Infant Growth & Gut Microbiome Development - A-MAGI

The National Institutes of Diabetes and Digestive and Kidney Disorders NIDDK0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • ââ?¬Â¢ Mother must be a participant in the A-PLUS trial
  • ââ?¬Â¢ Infant must be enrolled prior to discharge from the hospital after delivery
  • ââ?¬Â¢ Family must be planning to remain in the Nagpur area for the next 12 months

排除标准

  • ââ?¬Â¢ Infants with multiple congenital anomalies (e.g., cyanotic congenital heart disease, spina bifida, or other nervous system malformations) will be excluded.

研究者

发起方
The National Institutes of Diabetes and Digestive and Kidney Disorders NIDDK

相似试验